I see no reason short of a Hocking privatisation or pharma deal (lol) that the SP will not drift towards cash backing? 0.6c? There has been a consistent inability to get 1 decent commercial deal across the line. Again is it management or the technology, probably both.
Other comments... 1. Agree that the Hockings comment on the release is strange - Where is management? Who is calling the shots? 2. I see the Janssen payments as just helping to cover some costs really. Interesting to see what the prudent management of cash runway will be? 6-8 maybe quarters left of current spend. Staff cuts? 3. Good to see Bio-Link has been engaged yet again. Have they achieved anything of substance for PYC? Probably being unfair, but engage someone in the UK, Japan or the US on the ground who works with these pharmas.
bwb
PYC Price at posting:
1.2¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)